Evidence map›Paper›PMID 40501328›Full record

ArticleBJU international2025

Prostate artery EmbolisAtion Safety and efficacY: Preliminary and foLlow-Up urodynamic Studies (P-EASY PLUS).

Nicholas Brown, Sepinoud Firouzmand, Anthony Kiosoglous, Stephanie Castree, Duncan Walker, Rhiannon McBean, Boon Kua, Troy Gianduzzo, Rachel Esler, Peter Campbell and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicholas BrownThe University of Queensland, Brisbane, Qld, Australia.ORCID 0000-0002-8683-1897
Sepinoud FirouzmandI-MED Radiology Network, The Wesley Hospital, Auchenflower, Qld, Australia.
Anthony KiosoglousUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.
Stephanie CastreeI-MED Radiology Network, The Wesley Hospital, Auchenflower, Qld, Australia.
Duncan WalkerI-MED Radiology Network, The Wesley Hospital, Auchenflower, Qld, Australia.
Rhiannon McBean
Boon KuaUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.
Troy GianduzzoUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.ORCID 0000-0002-9683-3175
Rachel EslerUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.
Peter CampbellUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.
Joseph SchoemanUrology Craft Group, The Wesley Hospital, Auchenflower, Qld, Australia.
John YaxleyThe University of Queensland, Brisbane, Qld, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the efficacy of prostate artery embolisation (PAE) in the management of obstructive benign prostatic hyperplasia (BPH) by conducting formal urodynamic studies.

methodsPatients with symptomatic BPH underwent baseline assessments, including urodynamic evaluation, followed by PAE. Follow-up International Prostate Symptom Scores (IPSS), Quality of Life questionnaire (QoL) scores, prostate volume and urodynamic variables were assessed at a mean follow-up of 18 months.

resultsA total of 105 patients underwent PAE, with average final follow-up at 18 months. Prostate volumes reduced by a mean of 30.6% and significant improvements were identified across all IPSS parameters (total IPPS decreased by 55%; P < 0.001), QoL scores (improved by 65.9%; P < 0.001), maximum urinary flow rate (increased by 5 mL/s; P < 0.001), postvoid residual urine volume (decreased by 24%; P = 0.049), detrusor pressure (decreased from 65.0 to 48.9 cmH

conclusionIn this study, PAE resulted in statistically significant improvements by both subjective and objective measures, including symptom severity, quality of life and urodynamic parameters. Whilst longer-term studies are required, these findings support PAE as a non-surgical option within the treatment algorithm for managing symptomatic, obstructive BPH.

Indexed as

Embolization, TherapeuticProstateProstatic HyperplasiaUrodynamicsAgedAged, 80 and overArteriesFollow-Up StudiesHumansMaleMiddle AgedQuality of LifeTreatment Outcomebenign prostatic hyperplasiaembolisationLUTSPAEurodynamics

Identifiers

PMID40501328
PMCPMC12594276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.